HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Wolski Selected Research

Percutaneous Coronary Intervention

7/2006Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk.
4/2001Effect of smoking status and abciximab use on outcome after percutaneous coronary revascularization: Pooled analysis from EPIC, EPILOG, and EPISTENT.
7/2000Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Wolski Research Topics

Disease

3Myocardial Infarction
07/2006 - 03/2001
1Type 2 Diabetes Mellitus (MODY)
03/2014
1Hemorrhage
07/2006
1Acute Coronary Syndrome
04/2001
1Heart Diseases (Heart Disease)
04/2001
1Cardiovascular Diseases (Cardiovascular Disease)
03/2001
1Thrombocytopenia (Thrombopenia)
07/2000
1Pulmonary Tuberculosis
04/2000

Drug/Important Bio-Agent (IBA)

3Abciximab (ReoPro)FDA Link
04/2001 - 07/2000
1GhrelinIBA
03/2014
1Hormones (Hormone)IBA
03/2014
1Glucose (Dextrose)FDA LinkGeneric
03/2014
1Ticlopidine (Ticlid)FDA LinkGeneric
03/2001
1Platelet Membrane GlycoproteinsIBA
07/2000
1Heparin (Liquaemin)FDA LinkGeneric
07/2000

Therapy/Procedure

3Percutaneous Coronary Intervention
07/2006 - 07/2000
2Therapeutics
03/2014 - 07/2000
1Bariatric Surgery
03/2014
1Immunotherapy
04/2000